Interestingly, coagulation factor III and TFPI (also part of the coagulation pathway) were not different between the two groups, consistent with the observation that coagulopathy is a more prominent feature of severe COVID-19 than severe influenza infection [51]. Here, TFPI is linked to blood coagulation disease.